Skip to main content
logo
Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.360
+0.030 (0.69%)
At close: Jun 18, 2026, 4:00 PM EDT
4.280
-0.080 (-1.83%)
After-hours: Jun 18, 2026, 4:56 PM EDT

Atea Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
79.3295.7164.7143.82188.46764.38
Short-Term Investments
176.69206.12390.03434.28458.25-
Cash & Short-Term Investments
256.01301.83454.72578.11646.71764.38
Cash Growth
-39.83%-33.62%-21.34%-10.61%-15.39%-10.09%
Other Current Assets
7.199.167.6312.3514.218.03
Total Current Assets
263.2310.99462.36590.46660.92772.4
Net Property, Plant & Equipment
0.831.092.123.124.090.18
Other Long-Term Assets
3.053.140.21.41.690.31
Total Assets
267.08315.22464.67594.97666.71772.89
Accounts Payable
9.4512.954.464.252.554.53
Accrued Expenses
23.292613.3527.3615.2152.15
Current Portion of Leases
0.630.840.80.760.720.2
Total Current Liabilities
33.3739.7818.632.3818.4856.88
Long-Term Leases
--0.841.642.4-
Other Long-Term Liabilities
--6.365.765.265.93
Total Long-Term Liabilities
--7.27.47.665.93
Total Liabilities
33.3739.7825.839.7826.1462.82
Common Stock
0.080.080.080.080.080.08
Additional Paid-in Capital
801.74797.75802.77750.74701.05653.96
Accumulated Other Comprehensive Income
-0.10.170.230.21-0.68-
Retained Earnings
-568.01-522.57-364.22-195.84-59.8856.03
Shareholders' Equity
233.71275.43438.87555.19640.57710.08
Total Liabilities & Equity
267.08315.22464.67594.97666.71772.89
Total Debt
0.630.841.642.43.120.2
Net Cash (Debt)
255.37300.99453.08575.7643.59764.18
Net Cash Growth
-15.15%-33.57%-21.30%-10.55%-15.78%-10.11%
Net Cash Per Share
3.193.695.386.907.738.66
Book Value
233.71275.43438.87555.19640.57710.08
Book Value Per Share
2.923.385.216.667.698.05
Tangible Book Value
233.71275.43438.87555.19640.57710.08
Tangible Book Value Per Share
2.923.385.216.667.698.05
SEC Filings: 10-K · 10-Q